11,350 Shares in Elanco Animal Health (ELAN) Purchased by CIBC Asset Management Inc

Share on StockTwits

CIBC Asset Management Inc acquired a new stake in shares of Elanco Animal Health (NASDAQ:ELAN) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 11,350 shares of the company’s stock, valued at approximately $364,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Janus Henderson Group PLC increased its position in Elanco Animal Health by 377.9% during the 1st quarter. Janus Henderson Group PLC now owns 8,278,745 shares of the company’s stock valued at $265,499,000 after purchasing an additional 6,546,483 shares during the period. Amundi Pioneer Asset Management Inc. increased its position in Elanco Animal Health by 115,239.6% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 5,766,978 shares of the company’s stock valued at $181,833,000 after purchasing an additional 5,761,978 shares during the period. FMR LLC increased its position in Elanco Animal Health by 34.5% during the 4th quarter. FMR LLC now owns 4,415,172 shares of the company’s stock valued at $139,210,000 after purchasing an additional 1,131,504 shares during the period. Sound Shore Management Inc. CT purchased a new position in Elanco Animal Health during the 1st quarter valued at about $115,600,000. Finally, Massachusetts Financial Services Co. MA increased its position in Elanco Animal Health by 152.6% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,516,712 shares of the company’s stock valued at $110,881,000 after purchasing an additional 2,124,363 shares during the period.

ELAN has been the topic of a number of research reports. William Blair initiated coverage on shares of Elanco Animal Health in a research report on Monday, February 11th. They set a “market perform” rating and a $29.71 target price on the stock. Zacks Investment Research downgraded shares of Elanco Animal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, March 5th. Morgan Stanley initiated coverage on shares of Elanco Animal Health in a research report on Wednesday, March 13th. They set an “equal weight” rating and a $34.00 target price on the stock. Bank of America raised shares of Elanco Animal Health from a “neutral” rating to a “buy” rating and set a $30.95 price objective on the stock in a research report on Monday, March 18th. Finally, UBS Group initiated coverage on shares of Elanco Animal Health in a research report on Wednesday, March 20th. They issued a “sell” rating and a $28.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. Elanco Animal Health presently has a consensus rating of “Hold” and an average target price of $33.47.

In other news, Director John P. Bilbrey acquired 7,750 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were purchased at an average price of $32.39 per share, with a total value of $251,022.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director R David Hoover acquired 20,000 shares of the business’s stock in a transaction dated Wednesday, March 13th. The stock was purchased at an average cost of $31.43 per share, for a total transaction of $628,600.00. The disclosure for this purchase can be found here.

Shares of Elanco Animal Health stock opened at $32.10 on Friday. Elanco Animal Health has a 52-week low of $28.00 and a 52-week high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last issued its quarterly earnings data on Thursday, May 9th. The company reported $0.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.03. The firm had revenue of $731.10 million during the quarter, compared to analysts’ expectations of $743.40 million. During the same period in the previous year, the firm earned $0.33 EPS. The firm’s quarterly revenue was down .7% on a year-over-year basis.

ILLEGAL ACTIVITY NOTICE: “11,350 Shares in Elanco Animal Health (ELAN) Purchased by CIBC Asset Management Inc” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/4352934/11350-shares-in-elanco-animal-health-elan-purchased-by-cibc-asset-management-inc.html.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

Recommended Story: Diluted Earnings Per Share

Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Autoliv  PT Lowered to $62.00 at Buckingham Research
Autoliv PT Lowered to $62.00 at Buckingham Research
Shotspotter  Cut to “Market Perform” at Northland Securities
Shotspotter Cut to “Market Perform” at Northland Securities
Buckingham Research Increases Sonic Automotive  Price Target to $20.00
Buckingham Research Increases Sonic Automotive Price Target to $20.00
Vail Resorts  Earns Market Perform Rating from Analysts at Wells Fargo & Co
Vail Resorts Earns Market Perform Rating from Analysts at Wells Fargo & Co
Johnson Outdoors  Downgraded by Sidoti
Johnson Outdoors Downgraded by Sidoti
Autoliv  Stock Rating Upgraded by Robert W. Baird
Autoliv Stock Rating Upgraded by Robert W. Baird


© 2006-2019 Ticker Report